Estados financieros detallados de Benitec Biopharma Inc. (BNTC): cuenta de resultados, balance general y flujo de caja. Sigue la evolución de márgenes, deuda, liquidez y rentabilidad año a año con hasta 20 años de histórico.
Resumen del Análisis
Márgenes de los últimos 12 meses: margen bruto -14.2%, margen operativo -97.0%, margen neto -87.9%.
Al precio actual de $11.04, BNTC presenta beneficios negativos (P/E no significativo) y un ROE del -34.82%. La capitalización bursátil es de $379M.
Cuenta de Resultados (10 años)
| Año | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|
| Ingresos | $195882 | $4.4M | $17.4M | $97000 | $59000 | $73000 | $75000 | 0 | 0 | 0 |
| Coste de Ventas | $159999 | $473965 | $622173 | -$185000 | $123000 | $9000 | 0 | $343000 | $396000 | $481000 |
| Beneficio Bruto | $35881 | $3.9M | $15.9M | $282000 | -$64000 | $64000 | $75000 | -$343000 | -$396000 | -$481000 |
| I+D | $4.1M | $3.7M | $3.2M | $3.0M | $7.0M | $11.3M | $12.8M | $15.6M | $18.3M | $23.4M |
| Generales y Administrativos | $5.4M | $4.7M | $3.2M | $5.6M | $6.5M | $6.6M | $6.4M | $7.0M | $23.4M | $27.8M |
| Gastos Operativos | $12.2M | $16.6M | $13.1M | $8.6M | $13.5M | $17.9M | $19.2M | $22.5M | $41.4M | $50.7M |
| Beneficio Operativo | -$15.9M | -$8.7M | $3.7M | -$8.3M | -$13.6M | -$17.9M | -$19.1M | -$22.5M | -$41.8M | -$51.2M |
| EBITDA | -$3.2M | -$6.3M | $1.9M | -$7.9M | -$13.5M | -$17.8M | -$18.7M | -$22.1M | -$41.4M | -$51.2M |
| Gastos por Intereses | 0 | 0 | 0 | 0 | $6000 | $32000 | $33000 | 0 | -$3.3M | 0 |
| Beneficio Antes de Impuestos | -$3.3M | -$8.6M | $3.7M | -$8.3M | -$13.9M | -$18.2M | -$19.6M | -$21.8M | -$37.9M | -$45.5M |
| Impuestos | -$10.3M | -$4.2M | -$926824 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Neto | -$5.6M | -$12.3M | $3.7M | -$8.3M | -$13.9M | -$18.2M | -$19.6M | -$21.8M | -$37.9M | -$45.5M |
| BPA | $-63.55 | $-103.60 | $28.45 | $-69.09 | $-27.27 | $-19.31 | $-14.12 | $-2.68 | $-1.05 | $-0.98 |
| BPA Diluido | $-63.55 | $-103.60 | $28.45 | $-8.10 | $-27.27 | $-19.31 | $-14.12 | $-2.68 | $-1.05 | $-0.98 |
| Acciones en Circulación (Diluidas) | $137596 | $165064 | $201592 | $240280 | $1.0M | $1.9M | $1.4M | $10.3M | $36.2M | $46.6M |
Cuenta de Resultados (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Ingresos | 0 | 0 | 0 | 0 |
| Beneficio Bruto | -$118000 | -$120000 | -$119000 | -$124000 |
| Beneficio Operativo | -$9.8M | -$13.4M | -$13.6M | -$14.4M |
| EBITDA | -$9.7M | -$13.3M | -$13.5M | -$14.3M |
| Beneficio Neto | -$9.0M | -$11.8M | -$11.9M | -$12.8M |
| BPA | $-0.21 | $-0.26 | $-0.24 | $-0.27 |
| BPA Diluido | $-0.21 | $-0.26 | $-0.24 | $-0.27 |
Balance (10 años)
| Año | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|
| Caja y Equivalentes | $17.4M | $16.2M | $22.5M | $9.8M | $19.8M | $4.1M | $2.5M | $50.9M | $97.7M | $180.0M |
| Inversiones a Corto | $76845 | $22037 | $1430 | $1000 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cuentas por Cobrar | $3.5M | $4.3M | $5.2M | $59000 | $25000 | $3000 | $55000 | $229000 | $33000 | $4000 |
| Inventario | -$65065 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Corrientes | $22.2M | $21.0M | $26.8M | $10.8M | $20.6M | $4.8M | $3.7M | $51.7M | $98.5M | $181.7M |
| Inmovilizado Material | $341960 | $234334 | $469227 | $769000 | $577000 | $993000 | $613000 | $449000 | $991000 | $871000 |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Totales | $22.7M | $21.4M | $27.5M | $11.7M | $21.4M | $6.0M | $4.5M | $52.2M | $99.6M | $182.6M |
| Cuentas por Pagar | $133710 | $426063 | $1.5M | $282000 | $274000 | $422000 | $1.1M | $1.4M | $201000 | $913000 |
| Deuda a Corto | 0 | 0 | 0 | $192000 | 0 | 0 | 0 | 0 | 0 | 0 |
| Pasivos Corrientes | $864506 | $2.6M | $2.6M | $1.1M | $1.4M | $2.5M | $4.0M | $4.9M | $1.8M | $5.3M |
| Deuda a Largo | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $266000 |
| Pasivos Totales | $891402 | $2.6M | $2.6M | $1.5M | $1.4M | $3.1M | $4.3M | $5.0M | $2.3M | $5.6M |
| Reservas | -$136.2M | -$107.9M | -$108.9M | -$116.6M | -$130.1M | -$148.3M | -$167.9M | -$190.3M | -$228.2M | -$273.7M |
| Patrimonio Neto | $21.6M | $13.8M | $16.6M | $10.2M | $20.0M | $2.9M | $202000 | $47.2M | $97.3M | $177.0M |
| Deuda Total | 0 | 0 | 0 | $405000 | $213000 | $811000 | $559000 | $284000 | $849000 | $762000 |
| Deuda Neta | -$17.4M | -$16.2M | -$22.5M | -$9.4M | -$19.6M | -$3.3M | -$1.9M | -$50.6M | -$96.9M | -$179.2M |
| Capital Circulante | $21.4M | $18.4M | $24.2M | $9.7M | $19.2M | $2.3M | -$249000 | $46.8M | $96.7M | $176.3M |
Balance (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Caja y Equivalentes | $94.5M | $188.8M | $184.8M | $180.0M |
| Activos Totales | $96.0M | $190.7M | $187.0M | $182.6M |
| Pasivos Totales | $2.4M | $3.3M | $3.7M | $5.6M |
| Patrimonio Neto | $93.6M | $187.4M | $183.3M | $177.0M |
| Deuda Total | $817000 | $987000 | $876000 | $762000 |
Flujo de Caja (10 años)
| Año | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|
| Beneficio Neto | -$4.4M | -$8.6M | $2.6M | -$8.3M | -$13.9M | -$18.2M | -$19.6M | -$21.8M | -$37.9M | -$45.5M |
| Amortizaciones | $217000 | 0 | $158000 | $374000 | $424000 | $392000 | $381000 | $343000 | $396000 | $481000 |
| Compensación en Acciones | $386000 | 0 | $957196 | $237000 | $634000 | $870000 | $452000 | $830000 | $17.4M | $26.4M |
| Cambio en Capital Circulante | $760000 | $1.5M | $1.3M | $126000 | $8000 | $1.0M | $714000 | $1.2M | -$2.7M | $2.1M |
| Flujo de Caja Operativo | -$8.3M | -$8.6M | $4.8M | -$7.5M | -$12.8M | -$15.9M | -$18.0M | -$19.4M | -$23.6M | -$16.5M |
| Inversiones (CapEx) | -$131405 | -$60971 | -$403395 | -$95000 | -$221000 | -$13000 | -$1000 | -$179000 | -$18000 | -$105000 |
| Adquisiciones | 0 | 0 | $4000 | $1000 | 0 | 0 | 0 | 0 | 0 | 0 |
| Recompra de Acciones | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividendos Pagados | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Flujo de Caja Libre | -$8.4M | -$8.6M | $4.4M | -$7.6M | -$13.1M | -$15.9M | -$18.0M | -$19.6M | -$23.6M | -$16.6M |
Flujo de Caja (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Flujo de Caja Operativo | -$3.4M | -$3.8M | -$4.9M | -$4.9M |
| Inversiones (CapEx) | 0 | -$11000 | -$16042 | -$79000 |
| Flujo de Caja Libre | -$3.4M | -$3.8M | -$4.9M | -$5.0M |
| Dividendos Pagados | 0 | 0 | 0 | 0 |
| Compensación en Acciones | $5.2M | $7.4M | 0 | $6.3M |
Crecimiento y Márgenes (10 años)
| Año | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|
| Crecimiento Ingresos (anual) | | +2146.5% | +296.5% | -99.4% | -39.2% | +23.7% | +2.7% | -100.0% | | |
| Crecimiento Beneficio Neto (anual) | | -120.0% | +130.3% | -321.7% | -67.8% | -31.2% | -7.4% | -11.2% | -74.3% | -20.1% |
| Crecimiento BPA (anual) | | -63.0% | +127.5% | -342.8% | +60.5% | +29.2% | +26.9% | +81.0% | +60.8% | +6.7% |
| Cambio en Acciones (anual) | | +20.0% | +22.1% | +19.2% | +320.6% | +90.2% | -27.9% | +641.5% | +252.4% | +28.6% |
| Crecimiento FCF (anual) | | -2.1% | +150.9% | -273.9% | -71.1% | -21.9% | -13.2% | -8.7% | -20.5% | +29.6% |
| Margen Bruto | 18.3% | 89.7% | 91.1% | 290.7% | -108.5% | 87.7% | 100.0% | | | |
| Margen Operativo | -8132.4% | -198.4% | 21.2% | -8537.1% | -23044.1% | -24457.5% | -25441.3% | | | |
| Margen EBITDA | -1637.5% | -143.6% | 11.0% | -8151.5% | -22800.0% | -24361.6% | -24933.3% | | | |
| Margen Neto | -2860.4% | -280.1% | 21.4% | -8529.9% | -23528.8% | -24942.5% | -26082.7% | | | |
| Margen FCF | -4306.4% | -195.7% | 25.1% | -7866.0% | -22123.7% | -21797.3% | -24017.3% | | | |
| Tasa Impositiva Efectiva | 309.1% | 49.2% | -24.8% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% |
Datos por Acción (10 años)
| Año | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|
| FCF por Acción | $-61.31 | $-52.17 | $21.76 | $-31.75 | $-12.92 | $-8.28 | $-13.00 | $-1.91 | $-0.65 | $-0.36 |
| Dividendo por Acción | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Acciones en Circulación (Básicas) | $137592 | $165060 | $201592 | $240280 | $1.0M | $1.9M | $1.4M | $10.3M | $36.2M | $46.6M |
Qué mirar en Biotech
La mayoría de biotechs pequeñas pierden dinero. Analizarlas con P/E no tiene sentido — mira caja y pipeline.
- Cash Runway — Meses de caja al ritmo de gasto actual. <18 meses = riesgo de dilución urgente
- Cash burn anual — Ritmo al que queman caja operativa. Comparar con posición de caja para proyectar runway
- Total Debt — Biotech sin ingresos + deuda = receta para bancarrota
- I+D / Capitalización — Cuánto invierten en pipeline vs lo que vale la empresa — indicador de intensidad investigadora
- Market cap / Cash — Si cotiza cerca de su caja, el mercado le da ~0 valor al pipeline — puede ser oportunidad o trampa
Rentabilidad
| Rentabilidad sobre capital | -34.82% |
| Rentabilidad sobre capital invertido | -29.28% |
| Rentabilidad sobre activos | -26.14% |
| Margen bruto | -14.21% |
| Margen operativo | -9701.08% |
| Margen neto | -8792.09% |
Salud financiera
| Deuda / Patrimonio | 0.00 |
| Ratio corriente | 56.82 |
| Piotroski F-Score | 2 |
| Altman Z-Score | 107.24 |
Ratios Clave (10 años)
| Año | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|
| P/E | -9.64 | -6.61 | 9.64 | -1.95 | -2.65 | -1.02 | -0.29 | -2.71 | -11.14 | -13.65 |
| P/VC | 3.91 | 8.21 | 3.34 | 3.16 | 3.65 | 13.16 | 27.85 | 1.58 | 4.35 | 3.52 |
| P/V | 430.31 | 25.70 | 3.17 | 333.10 | 1237.65 | 519.41 | 75.02 | 0.00 | 0.00 | 0.00 |
| Margen Bruto | 18.3% | 89.7% | 91.1% | 290.7% | -108.5% | 87.7% | 100.0% | 0.0% | 0.0% | 0.0% |
| Margen Operativo | -8132.4% | -198.4% | 21.2% | -8537.1% | -23044.1% | -24457.5% | -25441.3% | 0.0% | 0.0% | 0.0% |
| Margen Neto | -2860.4% | -280.1% | 21.4% | -8529.9% | -23528.8% | -24942.5% | -26082.7% | 0.0% | 0.0% | 0.0% |